Medtronic, the global medical technology leader, held the official opening of its new offices which will oversee Medtronic’s operations in Asia and internationally (Latin America, Canada, Europe, Asia, Africa and Middle East, Australia). Medtronic also announced the establishment of a new additional manufacturing facility (Medtronic Singapore Operations or MSO) in Changi South to meet anticipated demand for cardiac devices in Asia.

“The opening of our SGD80 million manufacturing facility in Singapore is a very exciting development for Medtronic as we anticipate significant growth of the medical device industry in Asia and it will enable us to meet this rising need in an increasingly important market. By setting up our ASIA (ASEAN, South Korea, India, Australia and New Zealand) and International headquarters in Singapore, we are well placed to leverage on this growth and serve even more patients and customers in the future. I would like to take this opportunity to thank the Economic Development Board (EDB) for the strong support they have given us from the onset and look forward to when our manufacturing facility is in full operation,” stated Jean-Luc Butel, Executive Vice-President and Group President of Medtronic International.

The SGD80 million manufacturing facility in Singapore will be a state-of-the-art facility adhering to Medtronic’s high quality, safety and compliance standards. The facility will produce select Cardiac Rhythm Disease Management (CRDM) devices and production is expected to commence the beginning of 2011.